Oesophagogastric junctional adenocarcinoma

Oesophagogastric junctional adenocarcinoma is a cancer of the lower part of the oesophagus, often linked to a Barrett's oesophagus.

The incidence of oesophagogastric junctional adenocarcinoma is rising rapidly in western countries, in contrast to the declining frequency of distal gastric adenocarcinoma. Treatment options for adenocarcinomas involving the oesophagogastric junction are limited and the overall prognosis is extremely poor.

Oncogenetics

OGJ adenocarcinoma is a highly mutated and heterogeneous disease. Microsatellite instability (MSI) can be observed and coincides with an elevated number of somatic mutations. Potentially actionable coding mutations have been identified in 67 genes, including those in CR2, HGF, FGFR4 and ESRRB. Numerous genes harbouring somatic coding mutations and copy number changes in the microsatellite stable (MSS) OGJA are also known to be altered with similar predicted functional consequence in other tumour types. TP53, SYNE1, and ARID1A are among the most frequently mutated genes.[1]

References
  1. Chong, I. Y.; Cunningham, D; Barber, L. J.; Campbell, J; Chen, L; Kozarewa, I; Fenwick, K; Assiotis, I; Guettler, S; Garcia-Murillas, I; Awan, S; Lambros, M; Starling, N; Wotherspoon, A; Stamp, G; Gonzalez-De-Castro, D; Benson, M; Chau, I; Hulkki, S; Nohadani, M; Eltahir, Z; Lemnrau, A; Orr, N; Rao, S; Lord, C. J.; Ashworth, A (2013). "The genomic landscape of oesophagogastric junctional adenocarcinoma". The Journal of Pathology. 231 (3): 301–10. doi:10.1002/path.4247. PMID 24308032.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.